The role of the CD39–CD73–adenosine pathway in liver disease-Reference-Cited by-同舟云学术

The role of the CD39–CD73–adenosine pathway in liver disease

Published:2020-07-10 Issue:2 Volume:236 Page:851-862
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Wang Sheng¹²^ORCID,Gao Songsen³,Zhou Dexi¹,Qian Xueyi¹,Luan Jiajie¹,Lv Xiongwen²

Affiliation:

1. Department of Pharmacy The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College) Wuhu Anhui China

2. The Key Laboratory of Anti‐Inflammatory and Immune Medicines, Ministry of Education, School of Pharmacy, Institute for Liver Disease Anhui Medical University Hefei Anhui China

3. Department of Orthopedics (Spinal Surgery) The First Affiliated Hospital of Anhui Medical University Hefei Anhui China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.29932

Reference112 articles.

1. Activation of adenosine receptor A2A increases HSC proliferation and inhibits death and senescence by down-regulation of p53 and Rb

2. Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity

3. Targeting the CD73-adenosine axis in immuno-oncology

4. Rapid activation and hepatic recruitment of innate-like regulatory B cells after invariant NKT cell stimulation in mice

5. Inhibiting Adenosine Receptor Signaling Promotes Accumulation of Effector CD4+ T Cells in the Lung Parenchyma During Severe Tuberculosis

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The reduced frequency of CD39+CD73+ B cell subsets in SLE patients is correlated with disease activity;International Immunopharmacology;2024-10

2. Protective role of the CD73-A2AR axis in cirrhotic cardiomyopathy through negative feedback regulation of the NF-κB pathway;Frontiers in Immunology;2024-07-17

3. Enhancing hepatocellular carcinoma management: prognostic value of integrated CCL17, CCR4, CD73, and HHLA2 expression analysis;Journal of Cancer Research and Clinical Oncology;2024-06-25

4. Purinergic pathways and their clinical use in the treatment of acute myeloid leukemia;Purinergic Signalling;2024-03-06

5. Role of Natural Compounds Modulating Heme Catabolic Pathway in Gut, Liver, Cardiovascular, and Brain Diseases;Biomolecules;2024-01-02